The Weight of Affordability: GLP 1 Drugs' Hidden Cost to Employers and Employees The latest report from Milliman highlights a disturbing trend in employer healthcare costs: the skyrocketing expense of prescription drugs, particularly GLP 1 weight loss medications like Ozempic, Zepbound, and Wegovy.
These medications have been touted as game changers for weight management, but their rising cost is having a profound impact on employee out of pocket expenses.
The 2026 Milliman Medical Index report paints a dire picture of the financial burden shouldering families and employers alike.